BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20123000)

  • 41. Low Density Lipoprotein Cholesterol Decreases the Expression of Adenosine A
    Chaptal MC; Maraninchi M; Musto G; Mancini J; Chtioui H; Dupont-Roussel J; Marlinge M; Fromonot J; Lalevee N; Mourre F; Beliard S; Guieu R; Valero R; Mottola G
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro.
    Canfrán-Duque A; Casado ME; Pastor O; Sánchez-Wandelmer J; de la Peña G; Lerma M; Mariscal P; Bracher F; Lasunción MA; Busto R
    J Lipid Res; 2013 Feb; 54(2):310-24. PubMed ID: 23175778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lactoferrin perturbs intracellular trafficking, disrupts cholesterol-rich lipid rafts and inhibits glycolysis of highly metastatic cancer cells harbouring plasmalemmal V-ATPase.
    Santos-Pereira C; Guedes JP; Ferreira D; Rodrigues LR; Côrte-Real M
    Int J Biol Macromol; 2022 Nov; 220():1589-1604. PubMed ID: 36116593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sterol structure dependence of insulin receptor and insulin-like growth factor 1 receptor activation.
    Delle Bovi RJ; Kim J; Suresh P; London E; Miller WT
    Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):819-826. PubMed ID: 30682326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incorporation of exogenous lipids modulates insulin signaling in the hepatoma cell line, HepG2.
    Meuillet EJ; Leray V; Hubert P; Leray C; Cremel G
    Biochim Biophys Acta; 1999 May; 1454(1):38-48. PubMed ID: 10354513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sterol stringency of proliferation and cell cycle progression in human cells.
    Suárez Y; Fernández C; Ledo B; Martín M; Gómez-Coronado D; Lasunción MA
    Biochim Biophys Acta; 2005 May; 1734(2):203-13. PubMed ID: 15904877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Actin-dependent clustering of insulin receptors in membrane microdomains.
    Winter PW; Van Orden AK; Roess DA; Barisas BG
    Biochim Biophys Acta; 2012 Mar; 1818(3):467-73. PubMed ID: 22024024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulating insulin signaling and trafficking at the blood-brain barrier endothelium using lipid based nanoemulsions.
    Wang L; Wiedmann TS; Kandimalla KK
    Int J Pharm; 2022 Jun; 622():121823. PubMed ID: 35605891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of cholesterol biosynthesis and cancer signaling.
    Gorin A; Gabitova L; Astsaturov I
    Curr Opin Pharmacol; 2012 Dec; 12(6):710-6. PubMed ID: 22824431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipid Raft, Regulator of Plasmodesmal Callose Homeostasis.
    Iswanto AB; Kim JY
    Plants (Basel); 2017 Apr; 6(2):. PubMed ID: 28368351
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Plasmalemma Microdomains (Rafts) in Protection of the Plant Cell Under Osmotic Stress.
    Ozolina NV; Kapustina IS; Gurina VV; Bobkova VA; Nurminsky VN
    J Membr Biol; 2021 Aug; 254(4):429-439. PubMed ID: 34302495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alkylphospholipids: An update on molecular mechanisms and clinical relevance.
    Ríos-Marco P; Marco C; Gálvez X; Jiménez-López JM; Carrasco MP
    Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1657-1667. PubMed ID: 28238819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxia reduces the efficiency of elisidepsin by inhibiting hydroxylation and altering the structure of lipid rafts.
    Király A; Váradi T; Hajdu T; Rühl R; Galmarini CM; Szöllősi J; Nagy P
    Mar Drugs; 2013 Dec; 11(12):4858-75. PubMed ID: 24317474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DAMP, an acidotropic pH indicator, can be used as a tool to visualize non-esterified cholesterol in cells.
    Li W; Wang R; Zhang S; Li X
    Acta Biochim Biophys Sin (Shanghai); 2015 Feb; 47(2):73-9. PubMed ID: 25583734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Going the wrong road: Fyn and targeting of amyloid precursor protein to lipid rafts.
    Hartmann T; Prinetti A
    J Neurochem; 2011 Sep; 118(5):677-9. PubMed ID: 21689102
    [No Abstract]   [Full Text] [Related]  

  • 56. Modulators of cellular cholesterol homeostasis as antiproliferative and model membranes perturbing agents.
    Błaszczyk M; Kozioł A; Palko-Łabuz A; Środa-Pomianek K; Wesołowska O
    Biochim Biophys Acta Biomembr; 2023 Aug; 1865(6):184163. PubMed ID: 37172710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional roles for myosin 1c in cellular signaling pathways.
    Bond LM; Brandstaetter H; Kendrick-Jones J; Buss F
    Cell Signal; 2013 Jan; 25(1):229-35. PubMed ID: 23022959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholesterol-enriched membrane rafts and insulin secretion.
    Dirkx R; Solimena M
    J Diabetes Investig; 2012 Aug; 3(4):339-46. PubMed ID: 24843586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholesterol: A Prelate in Cell Nucleus and its Serendipity.
    Saxena N; Chandra NC
    Curr Mol Med; 2020; 20(9):692-707. PubMed ID: 32282300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haloperidol and insulin release.
    Lechin F; van der Dijs B
    Diabetologia; 1981; 20(1):78. PubMed ID: 7009289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.